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Abstract
Introduction
Gingival fibroblast-mediated extracellular matrix remodelling is implicated in the pathogene-
sis of periodontitis, yet the stimuli that regulate this response are not fully understood. The
immunoregulatory adipokine leptin is detectable in the gingiva, human gingival fibroblasts
express functional leptin receptor mRNA and leptin is known to regulate extracellular matrix
remodelling responses in cardiac fibroblasts. We therefore hypothesised that leptin would
enhance matrix metalloproteinase secretion in human gingival fibroblasts.
Methods and Results
We used in vitro cell culture to investigate leptin signalling and the effect of leptin on mRNA
and protein expression in human gingival fibroblasts. We confirmed human gingival fibro-
blasts expressed cell surface leptin receptor, found leptin increased matrix metalloprotei-
nase-1, -3, -8 and -14 expression in human gingival fibroblasts compared to unstimulated
cells, and observed that leptin stimulation activated MAPK, STAT1/3 and Akt signalling in
human gingival fibroblasts. Furthermore, leptin synergised with IL-1 or the TLR2 agonist
pam2CSK4 to markedly enhance matrix metalloproteinase-1 and -3 production by human
gingival fibroblasts. Signalling pathway inhibition demonstrated ERK was required for lep-
tin-stimulated matrix metalloproteinase-1 expression in human gingival fibroblasts; whilst
ERK, JNK, p38 and STAT3 were required for leptin+IL-1- and leptin+pam2CSK4-induced
matrix metalloproteinase-1 expression. A genome-wide expression array and gene ontol-
ogy analysis confirmed genes differentially expressed in leptin+IL-1-stimulated human gin-
gival fibroblasts (compared to unstimulated cells) were enriched for extracellular matrix
organisation and disassembly, and revealed that matrix metalloproteinase-8 and -12 were
also synergistically upregulated by leptin+IL-1 in human gingival fibroblasts.
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Conclusions
We conclude that leptin selectively enhances the expression and secretion of certain matrix
metalloproteinases in human gingival fibroblasts, and suggest that gingival fibroblasts may
have an ECM-degrading phenotype during conditions of hyperleptinaemia (e.g., obesity,
type 2 diabetes mellitus, exogenous leptin therapy).
Introduction
Gingival connective tissue is predominantly composed of stromal cells, such as fibroblasts, and
a collagen-rich extracellular matrix (ECM). Fibroblasts control the formation and remodelling
of the gingival ECM, through regulated expression of ECM components and ECM-remodelling
enzymes such as matrix metalloproteinases (MMPs) [1]. Fibrillar collagens are degraded by the
collagenolytic MMPs (MMP-1, MMP-8 and MMP-13) [2]. Excessive destruction of ECM pro-
teins, such as collagen, can be irreversible and is a feature of the common, chronic inflamma-
tory disease periodontitis. Therefore, ECM remodelling is tightly regulated [3]. Exogenous pro-
inflammatory stimuli such as bacterial lipopolysaccharide (LPS) are implicated in the patho-
genesis of periodontitis [4] and up-regulate the expression of several MMPs in human gingival
fibroblasts (HGFs) [5]. Additionally, the IL-6 family cytokine oncostatin-M (OSM), and IL-1
synergistically increase the secretion of MMP-1 by human gingival fibroblasts (HGFs) [6].
Obesity and type 2 diabetes mellitus are both positively associated with periodontitis [7],
however the molecular mechanisms underpinning this relationship are poorly characterised
[8]. The profile of circulating cytokines, growth factors and adipokines is altered in obese indi-
viduals and those with type 2 diabetes [9], and HGFs respond to many of these molecules. For
example, the adipokine adiponectin partially suppresses IL-1-stimulated IL-6 and IL-8 produc-
tion by HGFs [10]. Changes in the regulation, interactions and functionality of these mediators
may link obesity, diabetes and periodontitis [8]. Circulating levels of the adipokine leptin are
proportional to total adipose tissue mass, and the primary functions of leptin are to inform the
brain of energy reserves and to regulate energy expenditure [11]. However, leptin also plays
roles in angiogenesis, fertility, bone metabolism, immunity, wound repair and haematopoiesis,
and is classified as a member of the IL-6 cytokine family [12,13]. Leptin has been detected in
the gingiva by immunohistochemistry [14] and HGFs express functional leptin receptor
(LEPR) mRNA [15]. Functionally, leptin increases the secretion of IL-6 and IL-8 by HGFs [15].
In this study we examined whether leptin, either alone or in combination with inflammatory
mediators, could alter the expression of genes involved in ECM remodelling in HGFs, with a
focus on the collagenase MMP-1, and the stromelysin MMP-3. We found that leptin enhanced
the secretion of MMP-1 and MMP-3, and in combination with IL-1 synergistically up-regu-
lated MMP-1, MMP-3, MMP-8 and MMP-12 expression by HGFs. Mechanistically, we found
that leptin+IL-1-induced MMP-1 expression in HGFs was regulated by MAPK and STAT3
signalling.
Materials and Methods
Reagents and Antibodies
Recombinant human (rh) leptin was from Biotechne (Abingdon, UK). In most experiments
rhIL-1α was used as an IL-1 receptor agonist as described previously (Catterall, 2001); rhIL-1β
was a gift from Dr Keith Ray (GlaxoSmithKline, Stevenage, UK). In microarray experiments
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IL-1β (Biotechne) was used. RhOSM was prepared as described previously [16]. Pam2CSK4
and LPS from E. coli strain 0111:B4 were from Invivogen (Source Bioscience, Nottingham,
UK). Inhibitors of JNK (SP600125) and ERK (U0126) were from Biotechne, inhibitors of p38
(SB203580), STAT3 (S3I-201) and Akt (inhibitor VIII) were fromMerck Millipore (Watford,
UK). Monoclonal antibodies (Abs) against phospho-STAT1 (Y701), phospho-STAT3 (Y705),
STAT-3, phospho-p38 (T180/Y182), phospho-JNK (T183/Y185), phospho-ERK1/2 (T202/
Y204), ERK1/2 and phospho-Akt (S473) were from Cell-Signalling Technologies (New
England Biolabs, Hitchin, UK), GAPDH Ab fromMerck-Millipore, HRP-conjugated anti-
mouse and anti-rabbit Ig Abs from Dako (Ely, UK), IgG2B mouse LEPR and isotype control
PE-conjugated Abs from R&D Systems, IgG2A mouse Toll-like receptor (TLR)2 and TLR4
APC-conjugated Abs were from EBioscience (Hatfield, UK), and an isotype control APC-con-
jugated Ab was from AbD Serotec (Kidlington, UK). Except where indicated, all other reagents
were supplied by Sigma-Aldrich (Gillingham, UK).
HGF isolation and culture
Primary HGFs were derived from healthy gingival tissue obtained from patients with written
informed consent undergoing canine tooth exposure surgery, with ethical approval from the
National Research Ethics Service Committee North East (Reference: 07/Q1003/41). The tissue
was collected on ice into F-12 Ham’s medium, washed in PBS (both supplemented with 200
U/ml penicillin, 200 μg/ml streptomycin and 80 U/ml nystatin), dissected free of gingival epi-
thelium and cut into 2 mm3 sections. Sections were incubated (5% CO2 at 37°C) in DMEM
(containing 4.5 g/l glucose and supplemented with 100 U/ml penicillin, 100 μg/ml streptomy-
cin, 2 mM L-glutamine and 10% FBS) to allow HGF outgrowth. HGFs were maintained in
DMEM as previously described [17] and examined for morphology and expression of the
mesenchymal marker vimentin (Fig 1). Briefly, HGFs were fixed in methanol, then washed in
TBS (pH 7.6), prior to incubation with mouse monoclonal anti human vimentin Ab (IgG2b,
Clone Vim 3B4) (Dako) or diluent alone (3% FBS/TBS). After washing in TBS, HGFs were
incubated in Envision polymer (Dako) for 30 min. HGFs were washed again in TBS before
incubation in diaminobenzidine solution (Dako) for 5 min, then counterstained with haema-
toxylin. Excess diaminobenzidine and haematoxylin were removed by washing in water.
HGFs between passages 5 and 9 were serum-starved for 18 h before a 30 min pre-treatment
with chemical pathway inhibitors or DMSO (<0.1%), followed by stimulation with leptin
(0.1–25 μg/ml), IL-1 (0.05 ng/ml), OSM (5 ng/ml), pam2CSK4 (50 ng/ml) and/or LPS (10 ng/
ml) for 24 h as described previously [18–20]. Inhibitors and DMSO were used at concentra-
tions that were empirically demonstrated to have no adverse effect on HGF viability at 24 h
(not shown).
RNA extraction and RT-PCR
RNA was extracted using commercial kits (GenElute Mammalian Total RNAMiniprep Kit;
RNeasy Mini Kit, Qiagen, Manchester, UK; SideStep Lysis and Stabilization Buffer, Agilent
Technologies, Wokingham, UK) and reverse transcribed using the High-Capacity cDNA
Reverse Transcription kit (Life Technologies, Paisley, UK). Oligonucleotides and PrimeTime
qPCR probes (Integrated DNA Technologies, Glasgow, UK) used for real-time RT-PCR are
shown in Table 1. TaqMan assays for RNA polymerase II (RNAP) (POLR2AHs00172187_m1)
and Collagen Type 6A3 (COL6A3Hs00915125_m1) were from Life Technologies. For real-
time RT-PCR, relative gene expression levels were determined in cDNA samples using Taq-
Man Universal Master Mix (Life Technologies) and the ABI Prism 7900HT sequence detection
system (Life Technologies). Expression levels were normalised to RNAP. Primers used for
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conventional real-time RT-PCR are shown in Table 2. For RT-PCR, cDNA was amplified
using Bio-Mix Red PCR reaction mix (Bioline, London, UK) and analysed on 3.5% agarose gels
stained with Gel-Red (Biotium, Cambridge Bioscience, Cambridge, UK) using β2-microglobu-
lin (β2m) or 18S rRNA as a reference gene.
Fig 1. HGFmorphology and vimentin expression. (A) Light microscopy (100x magnification) of viable
HGFs at high confluency displaying characteristic fibroblast morphology. HGFs stained with (B) no antibody
control (C) anti-vimentin Ab. Images presented are from one donor and are representative of similar
micrographs form three donors stained independently.
doi:10.1371/journal.pone.0148024.g001
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ELISA, flow cytometry and immunoblotting
Culture supernatants from HGFs were analysed for total human MMP-1 and MMP-3 by
ELISA (R&D systems) according to the manufacturer’s protocol. These assays measure total
MMPs (i.e. both proenzymes and active forms) Expression of LEPR on the cell surface of
HGFs was analyzed by flow cytometry. 10,000 gated events were acquired on a FACSCalibur
flow cytometer (Becton Dickinson, Oxford, UK). Data were analyzed with WinMDI 2.8 soft-
ware (Joseph Trotter, The Scripps Research Institute, Purdue University, West Lafayette, IN,
USA). Western blotting was performed as described previously [18].
Microarray transcriptional profiling
HGFs from three donors were stimulated with leptin (10 μg/ml) ± IL-1β (0.05 ng/ml) for 24 h
in independent experiments and RNA was isolated using a RNeasy Mini Kit. Quality control,
RNA amplification, hybridisation onto the HumanHT-12 v4 expression beadchip (Illumina,
Little Chesterford, UK) and data generation were performed by Cambridge Genomic Services
(Cambridge, UK).
Table 1. Primer and probe sequences used for real-time RT-PCR.
Gene Forward Reverse Probe
MMP-1 50-AAGATGAAAGGTGGAC CAAAATT-
3
50-CCAAGAGAATGGCCGAG TTC-30 50-FAM-CAGAGAGTACAACTTACATCGTGTTGCGG
CTC-TAMRA-30
MMP-2 5’-TGGCGATGGATACCCC TTT-3’ 5’-TTCTCCCAAGGTCCATAG CTCAT-3’ 5’-FAM-CTCCTGGCTCATGCCTT CGCCC-TAMRA-3’
MMP-3 5’-TTCCGCCTGTCTCAAG
ATGATAT-3’
5’-AAAGGACAAAGCAGGAT CACAGT T-
3’
5’-FAM-TCAGTCCCTCTATGGACCT CCCCCTGAC-TAMRA-3’
MMP-7 5’-CTTTGCGCGAGGAGCT CA-3’ 5’-CAGGCGGAAAGGCATGA-3’ 5’-FAM-CCATTTGATGGGCCAGGA AACACG-TAMRA-3’
MMP-8 5’-CACTCCCTCAAGATGA CATCGA-
3’
5’-ACGGAGTGTGGTGATAG CATCA-3’ 5’-FAM-CAAGCAACCCTATCCAAC CTACTGGAC
CAA-TAMRA-3’
MMP-9 5’-CCTGGGCAGATTCCAA ACCT-3’ 5’-GCAAGTCTTCCGAGTAGT TTTGGA T-
3’
5’-FAM-CTCAAGTGGCACCACCAC AACATCACC-TAMRA-3’
MMP-
10
5’-GGACCTGGGCTTTATG
GAGATAT-3’
5’-CCCAGGGAGTGGCCAA GT-3’ 5’-FAM-CATCAGGCACCAATTTATC CTCGTTGCT-TAMRA-3’
MMP-
12
5’-CGCCTCTCTGCTGATG ACATAC-
3’
5’-GGTAGTGACAGCATCAA AACTCAA A-
3’
5’-FAM-TCCCTGTATGGAGACCCA AAAGAGAA CCA-TAMRA-
3’
MMP-
13
50-AAATTATGGAGGAGAT GCCCATT-
30
50-TCCTTGGAGTGGTCAAGA CCTAA-30 50-FAM-CTACAACTTGTTTCTTGTT GCTGCGCATGA-TAMRA-
30
MMP-
14
5’-AGGCCGACATCATGAT
CTTCTTT-3’
5’-AAGTGGGTGTCTCCTCCA ATGTT-3’ 5’-FAM-CCATGGCGACAGCACGCC CTT-TAMRA-3’
TIMP-1 5’-GACGGCCTTCTGCAAT TCC-3’ 5’-GTATAAGGTGGTCTGGTT
GACTTCTG-3’
5’-FAM-ACCTCGTCATCAGGGCCA AGTTCGT-TAMRA-3’
TIMP-2 5’-GAGCCTGAACCACAGG TACCA-
3’
5’-AGGAGATGTAGCACGGG ATCA-3’ 5’-FAM-CTGCGAGTGCAAGATCAC GCGC-TAMRA-3’
TIMP-3 5’- CCA GGA CGC CTT CTG CAA-3’ 5’- CCC CTC CTT TAC CAG CTT CTT C-
3’
doi:10.1371/journal.pone.0148024.t001
Table 2. Primer sequences used for conventional RT-PCR.
Gene Forward Reverse Product size
MMP-3 5’-TTCCGCCTGTCTCAAG ATGATAT-3’ 5’-AAAGGACAAAGCAGGAT CACAGT T-3’ 150 bp
18S rRNA 50-CGAATGGCTCATTAAA TCAGTTATG G-30 50-TATTAGCTCTAGAATTAC CACAGT TATCC-3 85 bp
LEPR 5’-GAAGATGTTCCGAACC CCAAGAATT G-3’ 5’-CTAGAGAAGCACTTGGT GACTGAA C-3’ 428 bp
β2m 5’-ACCCCCACTGAAAAAG ATGA-3’ 5’-CTTATGCACGCTTAACTA TC-3’ 425 bp
doi:10.1371/journal.pone.0148024.t002
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Expression datasets were normalised using the robust spline method and principal compo-
nent analysis was performed in R (Bioconductor, Seattle, WA, USA). Principle component
analysis identified that the datasets from one donor were different to the others in one dimen-
sion (not shown). This variation was eliminated using ComBat/surrogate variable analysis
[21,22]. The Human HT-12 v4 expression beadchip consists of> 47,000 probes and covers
31,000 genes. Differentially expressed genes for selected comparisons were determined as
those having a corrected p value of<0.01 (as assessed using Limma with Benjamini-Hochberg
correction for multiple comparisons) and a fold change2. Gene ontology (GO) overrepresen-
tation analysis (biological processes only) was performed using the GOstats Bioconductor
library in R. The datasets used in this study are deposited in Gene Expression Omnibus
(Ref: GSE68685) in accordance with Minimum Information About a Microarray Experiment
(MIAME).
Statistical analysis
Statistical analysis was performed using SPSS 15.0. Shapiro-Wilk testing for normality and
Levene testing for homogeneity of variance were performed prior to post hoc analyses of
parametric and non-parametric data by Student’s t test and MannWhitney U test respectively.
Real-time RT-PCR data were analysed using ΔCt values [23]. P values were corrected for multi-
ple comparisons using the Bonferroni-Holm correction. A P value of<0.05 was considered
significant.
Results
Leptin upregulates MMP expression in HGFs
Leptin increased the expression of the collagenaseMMP-1 in HGFs in a dose-dependent man-
ner (Fig 2A; Table 3). Similar effects on MMP-1 protein secretion were also observed in HGFs
(Fig 2B). This increased MMP-1 secretion was observed in a time-dependent manner (Fig 2C).
The collagenase MMP-8 was also upregulated by leptin in HGFs (Table 3). In contrast, the col-
lagenaseMMP-13 was not induced by leptin (Table 3). Leptin had no effect on the expression
of the gelatinases (MMP-2/MMP-9), the matrilysinMMP-7, the metalloelastaseMMP-12 and
tissue inhibitor of metalloproteinase (TIMP)-1-3, although most of these genes were expressed
basally in HGFs (Table 3). Similarly, leptin had no effect on the expression of the stromelysins
MMP-3 andMMP-10 in HGFs; however, the expression levels ofMMP-3 were low and not
consistently detected in all donors by RT-PCR. MMP-3 protein secretion in HGFs was
increased by leptin though the absolute levels of expression were donor-dependent ranging
between 51.9±5.2–1760±510 pg/ml (Fig 2D). Leptin increased the expression of the mem-
brane-typeMMP-14 in HGFs in a dose-dependent manner (Fig 2E). The related IL-6 family
cytokine OSM, but not IL-1, pam2CSK4 or LPS, similarly increasedMMP-14 expression (Fig
2F and 2G).
Leptin and IL-1 or pam2CSK4 synergistically upregulate MMP-1 and
MMP-3 expression in HGFs
Previous studies have demonstrated that IL-1 regulatesMMP-1/3 expression in HGFs [24,25],
and that IL-1 and OSM synergistically increase MMP-1 secretion by HGFs [6]. Since we found
that IL-1+OSM synergistically increasedMMP-1mRNA levels, and MMP-1 and MMP-3 pro-
tein secretion by HGFs (Fig 3), we stimulated HGFs with leptin+IL-1. We observed a synergis-
tic increase inMMP-1 andMMP-3mRNA levels and protein secretion in HGFs stimulated
with leptin+IL-1 (Fig 4A–4D). Leptin+IL-1 did not synergistically regulate the gene expression
Leptin Responses in Gingival Fibroblasts
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Fig 2. Effect of leptin on MMPmRNA and protein synthesis in HGFs.HGFs were stimulated with leptin
(0–25 μg/ml) for 24 h;MMP-1 gene expression was assessed by real-time RT-PCR (A) and supernatant
MMP-1 concentrations were assessed by ELISA (B). HGFs were stimulated with leptin (10 μg/ml) for 24 h or
the indicated durations and supernatant MMP-1 (C) and MMP-3 (D) concentrations were assessed by ELISA.
HGFs were stimulated with leptin (0–25 μg/ml) for 24 h andMMP-14 gene expression was assessed by real-
time RT-PCR (E). HGFs were stimulated with IL-1α (0.05 ng/ml) or OSM (5 ng/ml) alone, or in combination
with leptin (10 μg/ml) (F) and pam2CSK4 (50 ng/ml) or E. coli LPS (10 ng/ml) alone, or in combination with
leptin (10 μg/ml) for 24 h (G) andMMP-14 gene expression was determined by real-time RT-PCR. RT-PCR
data (fold control) are expressed relative to RNAP. Data (excluding Fig 2D) are presented as mean+SEM
Leptin Responses in Gingival Fibroblasts
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levels of membrane-typeMMP-14 (Fig 2F),MMP-2/MMP-9,MMP-7 or TIMP-1 in HGFs (not
shown). Next, we stimulated HGFs with leptin in the absence or presence of pam2CSK4 or
LPS, to assess synergy between leptin and these TLR agonists. Both TLR2 and TLR4 were
expressed on the surface of HGFs (Fig 5). Leptin+pam2CSK4 significantly increased the
expression ofMMP-1 gene and protein (Fig 4E and 4F respectively) and MMP-3 (Fig 4G) com-
pared to HGFs stimulated with leptin or pam2CSK4 alone. However, the absolute levels of
secreted MMP-1 and MMP-3 by leptin+pam2CSK4-stimulated HGFs were donor-dependent,
ranging between 3.65±0.32 −>42.0 ng/ml and 0.15±0.01–4.06 ±0.16 ng/ml respectively (Fig
4F and 4G). Interestingly, synergy between leptin and LPS forMMP-1 expression in HGFs was
also observed but again appeared to be donor-dependent only in one of three donors tested
(Fig 4H).
Leptin activates MAPK, STAT and Akt signalling in HGFs
HGFs express cell surface LEPR and the long isoform of the LEPR (Fig 6A). Stimulation of
HGFs with leptin, alone or in combination with IL-1 or pam2CSK4, activated multiple signal-
ling pathways (Fig 6B). Leptin activated the MAPK pathway in HGFs, as evidenced by phos-
phorylation of p38, JNK and ERK (Fig 6B). Leptin and OSM, but not IL-1 or pam2CSK4,
induced STAT1 and STAT3 tyrosine phosphorylation in HGFs. Similarly, phosphorylation of
Akt (at S473) in HGFs was induced by leptin and OSM, but not IL-1 or pam2CSK4 (Fig 6B).
Multiple signaling pathways control leptin+IL-1-induced MMP-1
expression
To investigate whether these identified signaling pathways regulated the expression of leptin-
induced MMP-1, HGFs were cultured in the presence of selective pathway inhibitors. The ERK
HGF cultures from 3 HGF donors stimulated in independent experiments (n = 4 from each donor). Remaining
data (Fig 2D) are expressed as mean+SD from 3 individual HGF donors (n = 4 from each donor). *P<0.05,
**P<0.01, ***P<0.001 compared to the unstimulated control at the same time point.
doi:10.1371/journal.pone.0148024.g002
Table 3. Basal and leptin-stimulated MMP and TIMP expression in HGFs.
Group Gene Basal expression Effect of leptin on mRNA expression Number of donors tested
Collagenase MMP-1 + Upregulated at  10 μg/ 7
MMP-8 + Upregulated at 10 μg/ml 4
MMP-13 - No effect 4
Gelatinase MMP-2 + No effect 3
MMP-9 - No effect 3
Stromelysin MMP-3 +/- No effect 4
MMP-10 + No effect 3
Matrilysin MMP-7 - No effect 3
Membrane-type MMP MMP-14 + Upregulated at  1 μg/ml 3
Other MMPs MMP-12 + No effect 3
TIMPs TIMP-1 + No effect 4
TIMP-2 + No effect 3
TIMP-3 + No effect 3
Gene expression was determined by real-time RT-PCR. + indicates basal gene expression in all donors, +/- indicates basal gene expression in some
donors, - indicates no basal gene expression in all donors assessed. ‘No effect’ indicates no effect at  25 μg/ml
doi:10.1371/journal.pone.0148024.t003
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Fig 3. Effect of IL-1 and OSM onMMP-1 andMMP-3 production by HGFs.HGFs were stimulated with IL-
1α (0.05 ng/ml), OSM (5 ng/ml) or IL-1α+OSM for 24 h. (A)MMP-1 gene expression was assessed by real-
time RT-PCR and data (fold control) are expressed relative to RNAP. Supernatant MMP-1 (B) and MMP-3 (C)
concentrations were assessed by ELISA. Data are presented as mean+SEM of three donors stimulated in
independent experiments (n = 4 for each donor). **P<0.01, ***P<0.001 compared to the unstimulated
control at the same time point.
doi:10.1371/journal.pone.0148024.g003
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Fig 4. Effect of leptin and IL-1, pam2CSK4 or LPS on MMP-1 andMMP-3 production by HGFs.HGFs were stimulated with leptin (10 μg/ml), IL-1α (0.05
ng/ml) or leptin+IL-1α for 24 h (A-D). HGFs were stimulated with leptin (10 μg/ml), pam2CSK4 (50 ng/ml), or leptin+pam2CSK4 for 24 h (E-G). Inset (G):
MMP-3 concentrations in HGFs isolated from donor 3 presented using an amplified scale. HGFs were stimulated with leptin (10 μg/ml), LPS (10 ng/ml) or
leptin+LPS for 24 h (H).MMP-1 gene expression was assessed by real-time RT-PCR and data (fold control) are expressed relative to RNAP with the
exception of Fig 4C which illustrates MMP-3 and 18S rRNA gene expression as assessed by RT-PCR and visualized on agarose gels. Supernatant MMP-1
concentrations were assessed by ELISA. Data (A, B, D, E) are presented as mean+SEM from 3 HGF donors stimulated in independent experiments (n = 4
Leptin Responses in Gingival Fibroblasts
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inhibitor U0126 significantly reducedMMP-1 expression in HGFs stimulated with leptin, IL-1
and pam2CSK4 both alone and in combination (Fig 6C). The JNK inhibitor SP600125 and
STAT3 inhibitor VI significantly reducedMMP-1 expression in HGFs stimulated with leptin
+IL-1 or leptin+pam2CSK4 (Fig 6D and 6E), whilst the p38 inhibitor SB203580 only signifi-
cantly reducedMMP-1 expression in HGFs stimulated with leptin+IL-1 (Fig 6F). Akt inhibitor
VIII at a concentration of 0.3 μM failed to inhibitMMP-1 gene expression in HGFs stimulated
with leptin, IL-1 and/or pam2CSK4 for 24 h (not shown). Thus, multiple signaling pathways
are involved in mediating leptin-inducedMMP-1 expression in HGFs.
Leptin+IL-1 alter the HGF transcriptome towards an ECM-degrading
phenotype
In order to assess the extent of genes involved in ECM remodelling altered by leptin+IL-1 in
HGFs, we conducted genome-wide transcriptional profiling by microarray. Numerous
genes relevant to ECM remodelling were significantly regulated in HGFs by leptin, IL-1 and
from each donor). Remaining data (F, G, H) are expressed as mean+SD from 3 individual HGF donors (n = 4 from each donor). *P<0.05, ***P<0.001
compared to the unstimulated control at the same time point.
doi:10.1371/journal.pone.0148024.g004
Fig 5. Surface TLR expression on HGFs.HGFs were prepared for flow cytometry. (A) The region highlighted in this dot plot was used to gate cells and omit
cellular debris. (B) Unstimulated HGFs were analysed for cell surface TLR2 and TLR4 expression by flow cytometry. These histograms are representative of
results from 4 different HGF donors.
doi:10.1371/journal.pone.0148024.g005
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Fig 6. Investigation of leptin receptor expression and signalling pathways leading to MMP-1 synthesis in HGFs. Flow cytometry for cell surface leptin
receptor expression on unstimulated HGFs (A). Data are representative of similar data from 4 HGF donors. Inset (A): long LEPR isoform (Ob-Rb) and β2m
gene expression as assessed by RT-PCR in unstimulated HGFs. Data are representative of similar results from 7 HGF donors. HGFs were stimulated with
leptin (10 μg/ml), IL-1 (0.05 ng/ml), pam2CSK4 (50 ng/ml), OSM (5 ng/ml), leptin+IL-1 or leptin+pam2CSK4 for 20 min and lysates immunoblotted with the
indicated antibodies including GAPDH as a loading control (B). The blots presented are all derived from the same donor and are representative of similar
results from 3 donors stimulated in independent experiments. (C) HGFs were pre-treated with the ERK inhibitor U0126 (7.5 μM), (D) the JNK inhibitor
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leptin+IL-1 compared to unstimulated HGFs (Table 4). Among these genes, the most upregu-
lated by leptin+IL-1 wereMMP3 andMMP1, whilst several collagen genes (e.g. COL6A3,
COL14A1, COL15A1) were down-regulated by leptin+IL-1 compared to the unstimulated con-
trol. Indeed, most of the genes related to ECM remodelling were only significantly regulated in
HGFs stimulated with leptin+IL-1 together, rather than these mediators alone, suggesting a
synergistic regulation. We found that several GO terms related to ECM remodelling were sig-
nificantly overrepresented in the differentially expressed gene list for leptin+IL-1-stimulated
HGFs compared to unstimulated controls (Table 5).
HGFs from three donors were stimulated with leptin (10 μg/ml), IL-1β (0.05 ng/ml) or lep-
tin+IL-1β for 24 h in independent experiments. RNA was extracted and used for genome-wide
expression analysis (Illumina microarray). Genes displayed were significantly differentially
expressed after leptin, IL-1 or leptin+IL-1 stimulation compared to unstimulated HGFs. The
numbers displayed indicate fold change in stimulated HGFs as compared to unstimulated
HGFs.—Indicates no change in gene expression.
These GO terms and example gene were significantly overrepresented in leptin+IL-1-stimu-
lated HGFs compared to unstimulated HGFs.
The effect of leptin and IL-1 on the expression of several genes highlighted by transcrip-
tional profiling (MMPs and COL6A3) was confirmed by real-time RT-PCR (Fig 7). Thus, leptin
and IL-1 synergistically increased the expression ofMMP-3,MMP-8 andMMP-12 in HGFs
(Fig 7A–7C). We also confirmed that the expression of COL6A3 was significantly lower in
HGFs stimulated with leptin+IL-1 compared to either leptin or IL-1 alone (Fig 7D). Finally, we
confirmed that leptin+IL-1 enhancedMMP-14 andMMP-2 expression in HGFs compared to
unstimulated cells (Fig 7E and 7F). However, increases inMMP-14 andMMP-2 expression in
HGFs were not due to synergy between leptin and IL-1; MMP-14 expression was stimulated by
leptin independently of IL-1 (as observed in Fig 2), whilst IL-1 stimulatedMMP-2 expression
independently of leptin. Although expression of leptin itself by HGFs was detected in the
microarrays this was only detected at very low levels and was not influenced by any of the
experimental treatments. Similarly, there was no evidence from the microarray experiments for
any effect of leptin in IL-1 expression.
Discussion
HGF-mediated ECM remodelling is implicated in the pathogenesis of periodontitis [1], but the
role of adipokines in regulating this effect is not fully understood. Leptin upregulates the secre-
tion of IL-6 and IL-8 by HGFs [15] and in the current study we demonstrated for the first time
that leptin upregulates MMP-1 and MMP-3 secretion in HGFs, alone and synergistically in
combination with IL-1 or pam2CSK4.
Leptin enhances the expression of MMPs in chondrocytes/cartilage [18,26] however, there
are no studies concerning leptin-stimulated MMP/TIMP expression in HGFs, or indeed in any
human fibroblasts. We demonstrated that the expression of certain MMPs (MMP-1, MMP-3,
MMP-8, MMP-14) with different substrate preferences and extracellular locations [3] were
upregulated by leptin in HGFs, which indicates that leptin stimulation of HGFs may result in
the remodelling of a broad range of ECM components (including fibrillar collagens). While
others have found TIMP-1mRNA and protein expression in HGFs is stimulated by LPS [5,27],
SP600126 (10 μM), (E) STAT3 inhibitor VI (100 μM), or (F) the p38 inhibitor SB203580 (10 μM) for 30 min and then stimulated with leptin (10 μg/ml), IL-1α
(0.05 ng/ml), pam2CSK4 (50 ng/ml), leptin+IL-1α or leptin+pam2CSK4 for 24 h.MMP-1 gene expression was assessed by real-time RT-PCR. Data (fold
unstimulated DMSO-pre-treated control) are expressed relative to RNAP. Data are presented as mean+SEM of three donors stimulated in independent
experiments (n = 4 for each donor). *P<0.05, **P<0.01, ***P<0.001 compared to the unstimulated control at the same time point.
doi:10.1371/journal.pone.0148024.g006
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Table 4. Genes functionally related to ECM homeostasis and proteolysis that were differentially expressed in HGFs treated with leptin and/or IL-1.
Type Symbol Gene name Fold change
(leptin+IL-1)
Fold change
(leptin)
Fold change
(IL-1)
MMPs MMP1 matrix metallopeptidase 1 13.0 - 4.3
MMP2 matrix metallopeptidase 2 2.4 - -
MMP3 matrix metallopeptidase 3 55.9 - 12.1
MMP8 matrix metallopeptidase 8 2.5 - -
MMP12 matrix metallopeptidase 12 2.0 - -
MMP14 matrix metallopeptidase 14 2.0 - -
Other metallopeptidases ADAM19 ADAM metallopeptidase domain 19 -3.0 -2.1 -2.6
ADAMTS1 ADAM metallopeptidase with
thrombospondin type 1 motif, 1
- 2.2 -
MME membrane metallo-endopeptidase 3.3 - 2.3
Collagens COL14A1 collagen, type XIV, alpha 1 -2.2 - -
COL15A1 collagen, type XV, alpha 1 -2.1 - -
COL5A1 collagen, type V, alpha 1 -2.0 - -
COL6A3 collagen, type VI, alpha 3 -2.8 - -
COL8A1 collagen, type VIII, alpha 1 - - 2.7
COL8A2 collagen, type VIII, alpha 2 -2.0 - -
Serine proteases DPP4 dipeptidyl-peptidase 4 2.1 - -
PLAT plasminogen activator, tissue 2.6 - -
PRSS12 protease, serine, 12 -2.4 - -
PRSS23 protease, serine, 23 -6.0 - -2.4
Endopeptidase inhibitors PI3 peptidase inhibitor 3, skin-derived 8.5 - 2.4
SLPI secretory leukocyte peptidase inhibitor 2.5 - -
TIMP3 TIMP metallopeptidase inhibitor 3 -2.3 - -
Serine protease inhibitors KAZALD1 Kazal-type serine peptidase inhibitor
domain 1
-2.3 - -
SERPINA3 serpin peptidase inhibitor, clade A,
member 3
2.3 - -
SERPINB2 serpin peptidase inhibitor, clade B,
member 1
2.1 - -
SERPINB4 serpin peptidase inhibitor, clade B,
member 4
3.3 - -
SERPINB7 serpin peptidase inhibitor, clade B,
member 7
2.0 - -
SERPING1 serpin peptidase inhibitor, clade G,
member 1
- 2.0 -
SERPINI1 serpin peptidase inhibitor, clade I,
member 1
-2.3 - -
Glycoproteins localised to ECM EFEMP1 EGF containing fibulin-like extracellular
matrix protein 1
- 2.1 -
THBS1 thrombospondin 1 3.3 - -
THBS4 thrombospondin 4 -2.0 - -
TNC tenascin C 4.3 - 3.8
Proteins localised to ECM LAMA5 laminin, alpha 5 -2.0 - -
LAMB3 laminin, beta 3 3.1 - -
MATN2 matrilin 2 -2.2 - -
MGP matrix Gla protein -4.0 - -2.9
NTN4 netrin 4 -2.2 - -
OGN osteoglycin -2.3
(Continued)
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we found no differences in TIMP gene expression in HGFs stimulated by leptin, IL-1, OSM,
LPS or pam2CSK4 suggesting that leptin could promote ECM remodelling by HGFs by
increasing the active MMP:TIMP ratio.
In agreement with previous work investigating cytokine synthesis in HGFs [28,29] we
observed that MMP responses to both LPS and pam2CSK4, and leptin-stimulated MMP-3
responses were qualitatively but not quantitatively similar between HGFs from different
donors. These differences might be explained by genetic and/or epigenetic differences between
individuals although this requires systematic investigation.
We demonstrated that leptin and IL-1 synergistically increase the expression of multiple
MMPs (MMP-1, MMP-3, MMP-8, MMP-12) in HGFs. The fold change inMMP-1 expression
in leptin+IL-1-stimulated HGFs in this study was approximately 10 times higher than that
observed in a previous study in chondrocytes using the same concentrations of leptin and IL-1
[18]. Also, to our knowledge, this is the first report of synergy between leptin and a TLR2 ago-
nist (pam2CSK4) in any primary human cells. These results indicate that the potential for HGF-
mediated ECM remodelling may be greatly enhanced under simultaneous hyperleptinaemic
Table 4. (Continued)
Type Symbol Gene name Fold change
(leptin+IL-1)
Fold change
(leptin)
Fold change
(IL-1)
POSTN periostin -2.7 - -2.1
Other ECM components or regulators of
ECM components
CSPG4 chondroitin sulfate proteoglycan 4 -2.0 - -
HAS3 hyaluronan synthase 3 2.3 - -
PLOD2 procollagen-lysine, 2-oxoglutarate
5-dioxygenase 2
2.8 - -
VCAN versican -2.8 - -2.4
Other peptidases or regulators of
proteolysis
CASP3 caspase 3, apoptosis-related cysteine
peptidase
2.9 - -
CTSL cathepsin L 3.3 3.6 -
LAP3 leucine aminopeptidase 3 2.9 - -
PCOLCE2 procollagen C-endopeptidase enhancer
2
-2.5 - -
PLAUR plasminogen activator, urokinase
receptor
2.7 - -
doi:10.1371/journal.pone.0148024.t004
Table 5. GO terms relevant to ECM homeostasis and proteolysis are significantly over-represented in HGFs stimulated with leptin and IL-1.
GO term Adjusted P
value
Example genes up Example genes down
GO:0009611 response to wounding 7.66E-18 PLAT, TNC, CASP3, SERPINB2
GO:0030198 extracellular matrix
organization
5.72E-10 MMP3, MMP1, THBS1, LAMB3, PLOD2, MMP8,
HAS3, MMP14, MMP12
POSTN, NTN4, KAZALD1,
LAMA5
GO:0043062 extracellular structure
organization
5.72E-10 MMP3, MMP1, THBS1, LAMB3, PLOD2, MMP8,
HAS3, MMP14, MMP12
POSTN, NTN4, KAZALD1,
LAMA5
GO:0022617 extracellular matrix
disassembly
3.76E-05 MMP3, MMP1, LAMB3, MMP8, MMP14 LAMA5
GO:0032963 collagen metabolic process 3.62E-05 MMP3, MMP1, MMP8, MMP2, MMP14, MMP12
GO:0030574 collagen catabolic process 0.000725
GO:0052547 regulation of peptidase
activity
0.00176 PI3, SERPINB4, SLPI, SERPINA3, SERPINB2 TIMP3, COL6A3, PCOLCE2,
SERPINI1
doi:10.1371/journal.pone.0148024.t005
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Fig 7. Confirmation of the microarray dataset by real-time RT-PCR. HGFs were stimulated with leptin (10 μg/ml), IL-1β (0.05 ng/ml) or leptin+IL-1β for 24
h. Real-time RT-PCRwas used to assess (A)MMP-3, (B)MMP-8, (C)MMP-12, (D) collagen 6A3 (COL6A3), (E)MMP-14, and (F)MMP-2 gene expression.
Data are expressed relative to RNAP and are presented as mean+SEM from three donors stimulated in independent experiments (n = 4 for each donor).
*P<0.05, **P<0.01, ***P<0.001 compared to the unstimulated control at the same time point.
doi:10.1371/journal.pone.0148024.g007
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and proinflammatory conditions, which could disturb ECM homeostasis and promote deleteri-
ous ECM degradation as is observed in periodontitis. Furthermore, leptin increases MMP-14
protein production and surface expression in primary rat cardiac fibroblasts [30]; similarly, lep-
tin (and OSM) increased MMP-14 expression in HGFs in this study suggesting a role for IL-6
family cytokines in regulating pericellular ECM remodelling by HGFs.
All the short isoforms of the LEPR are expressed at the mRNA level by HGFs [15], including
the long LEPR isoform in accordance with the data presented herein. Leptin activates the
MAPK, JAK/STAT, and PI3K/Akt signalling pathways in HGFs; these are some of the well
characterised signalling responses activated downstream of the long LEPR isoform [31].
Together with the finding that HGFs express cell surface LEPR, these data suggest that HGFs
are sensitive and responsive to leptin.
ERK is known to regulate MMP-1 expression in IL-1-stimulated HGFs [32,33], and in lep-
tin-stimulated chondrocytes/cartilage [18,26]. We showed that ERK regulates MMP-1 expres-
sion in HGFs stimulated with leptin, IL-1 and pam2CSK4 alone and in combination. Similarly,
MAPK and STAT signalling pathways clearly regulate MMP-1 expression in HGFs stimulated
by leptin+IL-1 as has been shown in chondrocytes [18]. We also showed that MMP-1 expres-
sion stimulated by leptin and pam2CSK4 is regulated by MAPK and STAT signalling. Multiple
mechanisms, such as direct binding to theMMP-1 promoter [34,35], crosstalk between signal-
ling pathways [36], and chromatin remodelling [37] could underpin the requirement for
STAT3 in regulating MMP-1 expression in HGFs. Additionally, functional redundancy
between STAT family members could add another dimension to this mechanism [38]. Interest-
ingly, Akt inhibitor VIII did not inhibit leptin (+IL-1/pam2CSK4)-induced MMP-1 expression
by HGFs, which could be attributed to a requirement to use lower concentrations of this inhibi-
tor than other studies [18,39] due to a cytotoxic effect in HGFs (not shown). Together, our
results suggest that leptin and pro-inflammatory mediators stimulate specific and coordinated
gingival fibroblast signalling events that determine the production of the collagenase MMP-1.
Transcriptional profiling revealed thatMMP-8 andMMP-12 were most upregulated in
HGFs after stimulation with both leptin and IL-1 together. While MMP-8 in the periodontium
is predominantly thought to be neutrophil-derived [40,41], there is evidence that other cells in
the periodontium such as plasma cells, ‘macrophage-like cells’, sulcular epthielial cells as well
as HGFs synthesise MMP-8 [25,41]. The elastase MMP-12 can activate itself and other MMPs
through autolytic processing [42], providing a putative mechanism by which the initial activa-
tion of HGF-derived MMPs upregulated by leptin+IL-1 could occur. Interestingly, leptin+IL-1,
as compared to leptin or IL-1 alone, synergistically regulated a wide range of genes relevant to
ECM remodelling not limited to MMPs including collagens and other enzymes as well as cer-
tain cytokines and chemokines (unpublished observations). Studies that investigate the full
extent of the HGF phenotype induced by leptin and the functional implications of this, in rela-
tion to ECM remodelling and to broader inflammatory responses in the gingiva are clearly
required, and may help to address the possible redundancy between leptin and other IL-6 fam-
ily members (e.g. OSM).
Circulating leptin concentrations are proportional to adipose tissue mass, and as such leptin
has been shown to indicate organismal energy status to several tissues/organs [11] and also
influence the immunocompetence of leukocytes [43]. We hypothesise that leptin could serve to
inform HGFs of the energy status of an organism, thereby ensuring that the responses of HGFs
(e.g. ECM remodelling) are in line with energy availability but are influenced by inflammatory
context. For example, the presence of high concentrations of leptin in the inflamed gingiva
(and hence a pro-inflammatory cytokine milieu) may synergistically drive HGF-mediated
ECM degradation.
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We conclude that leptin, in synergy with pro-inflammatory stimuli (IL-1 and the TLR-2
agonist pam2CSK4) selectively enhances MMP-1 and MMP-3 secretion in HGFs and suggest
that gingival fibroblast-mediated ECM degradation, may be deleteriously enhanced during
conditions of hyperleptinaemia (e.g. obesity, type 2 diabetes mellitus, exogenous leptin
therapy).
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